1Wei H, Hai W, Wanqing L. Clinical study on liposomal amphoeericin B [ Ambisome (R) ] in deep fungal infeetions in China [ J ]. Mycoses, 2003,46(1-2) :24-28.
2Garber G. An overwiew of fungal infections [ J ]. Drugs, 2001,61 ( Suppl 1 ) :1-12.
3Hanson DL, Faizo KM. Distribution of CD4 T lymphocytes at diagnosis of acquired immunodeficiency syndrome defining and other human immunodeficiency virus - related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project [J]. Group Arch Intern Med,1995,155:1537-1542.
4Chang T, Teng MM, Wang SF, et al. Aspergillosis of the paranasal sinuses[J]. Neuroradiology, 1992,34 : 520-523.
5Lakshmi V, Sudha T, Teja VD, et al. Prevalence of central nervous system cryptocoecosis in human immunodeficieney virus reactive hospitallizen patients[J], Indian Journal of Medical Microbiology, 2007, 25:146-149.
6Kazuhiro U, Yasuo K. Brain MRI findings in cryptococcal meningoencephalitis [J]. J Nippon Med Sch, 2000, 67(4) :226-227.
7Tien RD, Chu PK, Hesselink JR, et al. Intracranial cryptococcosis in immunocompromized patients: CT and MR findings in 29 cases[J]. AJNR Am J Neuroradiol,1991,12:283-289.
8Ruzi A, Post MJD, Bundschu CC. Denate nuclei involcement in AIDS patients with CNS crytococosis : imaging finding with pathologic correlation[J]. J Comput Assist Tomogr, 1997,21 (2) : 175-182.
9Seikou K, Masui K, Shigetoshi UGA. Cryptococcal meningoencephalitis presenting with an unusual magnetic resonance imaging appearance[J]. Neurol Med Chir (Tokyo), 2001,41:517-521.
10Jain K, Mittal K. Imaging features of central nervous system fungal infections[J]. Neurology India, 2007,55:241-250.
1YC Lee, Wang JT. Sun HY, et al. Comparisons of clinical features and mortality of ct3.'ptococcal meningitis between patients with and without human immunodeficiency virus infection[ J ]. Microbiolimmu- nolinfect,2011,44(5 ) :338-345.
2Eisenman HC, Arturo C. Synthesis and assembly of fangal melanin [ J ]. Applied Microbiology & Biotechnology ,2012,93 ( 3 ) :931-940.
3Price MS, Betancourt-Quiroz M. Price JL,el al. Cryptococcus neofor- roans requires a functional glycolytic pathway for disease but no! per- sistence in the host [ J ]. Mhio,2011,2 ( 3 ) : 103-111.
4Cohen DB, Zijlstra EE. Mukaka M, et al. Diagnosis of cryptococeal and tuberculous meningitis in a resource-limited African setting[ J ]. Tropical Medicine & International Health ,2010,15 ( 8 ) :910-917.
5Linden RA, Pappas PG, Prefect J, eta|. Phase 1 Evaluation of the Safety and Pharmaeokinetics of Murine-Derived Anticryptocnccal An- tibody 18B7 in Subjects with Treated Cryptococcal Meningitis[ J ]. Autimicmb Agents Chemother,2005,49( 3 ) :952-958.
